Voloridge Investment Management, LLC Halozyme Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $12 Million - $16.7 Million	-318,196 Reduced 79.89%	80,110 $4.19 Million
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $11.6 Million - $14.4 Million	343,572 Added 627.71%	398,306 $16.2 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $1.82 Million - $2.3 Million	54,734 New	54,734 $2.02 Million
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $5.64 Million - $8.37 Million	140,847 Added 197.74%	212,076 $12.1 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $11.4 Million - $15.4 Million	-296,894 Reduced 80.65%	71,229 $2.82 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $8.41 Million - $10.9 Million	225,287 Added 157.72%	368,123 $16.2 Million
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $3.61 Million - $4.64 Million	-112,950 Reduced 44.16%	142,836 $5.7 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $4.52 Million - $5.78 Million	141,961 Added 124.72%	255,786 $10.3 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $4.38 Million - $5.28 Million	113,825 New	113,825 $4.63 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $8.07 Million - $10.5 Million	-204,136 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $4.37 Million - $7.38 Million	-169,237 Reduced 45.33%	204,136 $8.72 Million
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $2.01 Million - $2.32 Million	78,200 Added 26.49%	373,373 $9.81 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $4.8 Million - $7.91 Million	295,173 New	295,173 $7.91 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $1.38 Million - $2.16 Million	-99,168 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $1.48 Million - $1.94 Million	99,168 New	99,168 $1.76 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account